Past obstetric history and risk of ovarian cancer

Annals of Agricultural and Environmental Medicine

Volumn 19, Issue 3, 2012, Pages 385-388

  Pieta, Beata ^a   Chmaj Wierzchowska, Karolina ^a   Opala, Tomasz ^a  

^a POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

Author keywords

Ovarian cancer; Reproductive factors; Risk factors

Indexed keywords

ARTICLE; BREAST FEEDING; CANCER RISK; CONTROLLED STUDY; FEMALE; HUMAN; LIVE BIRTH; MAJOR CLINICAL STUDY; MATERNAL AGE; MENARCHE; MENOPAUSE; OVARY CANCER; PREGNANCY TERMINATION; PRIMIPARA; REPRODUCTIVE HEALTH; SPONTANEOUS ABORTION;

ADULT; AGE FACTORS; FEMALE; HUMANS; MIDDLE AGED; ODDS RATIO; OVARIAN NEOPLASMS; POLAND; PREGNANCY; QUESTIONNAIRES; REPRODUCTIVE HISTORY; RISK FACTORS;

EID: 84866661808     PISSN: 12321966     EISSN: 18982263     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Markowska J, Ma{ogonek}dry R. Ginekologia onkologiczna. (Oncologic gynaecology). MedPharm Polska, 2008, p. 297 (in Polish).
2. Hossfeld DK, Sherman CD, et al. Podre{ogonek}cznik onkologii klinicznej (Handbook of clinical oncology). Wydawnictwo Naukowe PWN, Kraków 1994: p. 37-90 (in Polish).
3. Spaczyński M, Karowicz-Bilińska A, et al. Cost of Population Cervical Cancer Screening Program in Poland between 2007-2009. Ginekol Pol. 2010; 81(10): 750-756.
4. Nowakowski A, Kotarski J. Nowoczesna pierwotna profilaktyka raka szyjki macicy. (Modern primary prevention of cervical cancer). Zakażenia 2008; 1: 82-88 (in Polish).
5. Ulman-Włodziarz I, Nowosielski K, Romanik M, Pozowski J, Jurek M. Awareness of cervical cancer prevention among patients of gynecological outpatient clinic. Ginekol Pol. 2011; 82(1): 22-25.
6. Spaczyński M, Karowicz-Bilińska A, et al. Attendance rate in the Polish Cervical Cancer Screening Program in the years 2007-2009. Ginekol Pol. 2010; 81(9): 655-663.
7. Pie{ogonek}ta B, Grodecka-Gazdecka S, Chmaj-Wierzchowska K, Kramer L, Opala T. Analiza ilorazu szans zachorowania na nowotwory złośliwe gruczołu piersiowego. (Analysis of odds ratio for developing malignant breast cancer of malignant). Ginekol Pol. 2011; 82(10): 755-760.
8. Kordek R. (Ed.). Onkologia. Podre{ogonek}cznik dla studentów i lekarzy. (Oncology. Handbook for students and physicians). VIA MEDICA, 2007, p. 390 (in Polish).
9. Markowska J. (Ed.). Onkologia Ginekologiczna (Oncology Gynaecological). Vol. 2. URBAN&PARTNER. 2002, p. 1002 (in Polish).
10. Słomko Z. (Ed.). Ginekologia. (Gynaecology). Wydawnictwo Lekarskie PZWL, Warszawa 2008, 623-676 (in Polish).
11. Iwanowicz-Palus G, Lewicka M. Styl życia jednym z czynników ryzyka zachorowania na raka piersi. (Life style as one of breast cancer risk factors). Wiad Lek. 2004; 57 (supl.1): 108-112 (in Polish).
12. Kuś E, Świerczewski A, Estemberg D, Kowalska-Koprek U, Brzozowska M, Berner-Tra{ogonek}bska M, Grabicka A, Karowicz-Bilińska A. Course of pregnancy and delivery in a patient with ovarian cancer after conservative surgical treatment-case report. Ginekol Pol. 2010; 81(1): 65-68.
13. Markowska A, Pawałowska M, Markowska J, Litwiniuk M, Ma{ogonek}dry R, Dilmaghani-Tabriz D. Influence of oncological treatment on fertility of women and pregnancy outcome. Ginekol Pol. 2010; 81(6): 446-451.
14. Niwińska A. Hormonalne uwarunkowania raka sutka. (Hormonal conditioning of breast cancer). Ginek Pol. 1997; 68: 558-562 (in Polish).
15. Anastiasiadis P, Koutlaki N, Skaphida P, et al. Ovarian cancer epidemiology In Thrace, Greece. Eur J Gynecol Oncol. 2000; XXI (3): 298.
16. Ke{ogonek}dzia H, Ke{ogonek}dzia W. Nowotwory narza{ogonek}dów płciowych kobiety. Diagnostyka patomorfologiczna, poste{ogonek}powanie kliniczne. (Cancers of the female reproductive system. Diagnostics, pathomorphology, clinical management). MedPharm Polska, Wrocław 2012, p. 281 (in Polish).
17. Jassem J. Rak sutka. Podre{ogonek}cznik dla studentów i lekarzy. (Breast cancer. Handbook for students and physicians). Springer PWN, Warszawa 1998.
18. Zadrożny M. Poste{ogonek}powanie w złośliwych i łagodnych schorzeniach sutka. Diagnostyka i terapia wieku menopauzalnego. (Management of malignant and benign breast diseases. Diagnostics and therapy at menopausal age) Pertyński T. (Ed.). Urban&Partner, Wrocław, 2004 (in Polish).
19. Gabryś MSt, Popiela A, Popiela M, Mazur R. Rak jajnika w aspekcie profilaktyki zagrożeń onkologicznych. (Ovarian cancer from the aspect of oncologic risk). Pol Med Rodz. 2004; 6(3): 837-843 (in Polish).
20. Markowska A. Przegla{ogonek}d teorii rozwoju raka jajnika. Leptyna jako potencjalny czynnik biora{ogonek}cy udział w karcynogenezie. (Review of theories of ovarian cancer development. Leptin as a potential factor participating in carcinogenesis). J Oncol. 2007; 57: 518-523 (in Polish).
21. Franceschi S, La Vecchia C, Booth M, et al. Pooled analysis of 3 European Case-control studies of ovarian cancer. Age at menarche and menopause. Int J Cancer. 1991; 49: 57.
22. Parazzini F, Chatenoud L, Chiantera V, et al. Population attributable risk for ovarian cancer. Eur J Cancer. 2000; 36: 520-524.
23. Kutarska E. Rak jajnika-drogi poprawy efektywności leczenia. (Ovarian cancer-ways towards improvement of the effectiveness of treatment). Onkologia i Radioterapia. (Ovarian cancer 2007; 1(1): 26-38 (in Polish).
24. Bulsa M, Czaja-Bulsa G. Profilaktyka raka jajnika. (Ovarian cancer prevention). Family Medicine&Primary Care Review 2006; 8(2): 375-376 (in Polish).
25. Baker J, Odunuga O, Rodabangh K, et al. Active and passive smoking and risk ovarian cancer. Ovarian cancer: Prevention and detection of the disease and its recurrence. Molecular Targers and the Immune System. Symposium Pittsburgh. 19 May 2005, Abstract.
26. Nowak-Markwitz E, Spaczyński M. Rak jajnika-nowe spojrzenie na pochodzenie i histogeneze{ogonek} (Ovarian cancer-new approach to its origin and histogenesis). Ginecol Pol. 2012; 83: 454-457 (in Polish).
27. Ness RB, Cottreau C. Possible role of ovarian epithelial inflammation in ovarian cancer. Review J Natl Cancer Inst. 1999; 91: 1459-1467.
28. Bednarek W, Mazurek M, Ćwiklińska A, Barczyński B. Expression of select angiogenesis markers and modulators in pre-, peri-, and postmenopausal women with ovarian cancer. Ginekol Pol. 2009; 80(2): 88-92.